Lv1
38 积分 2025-07-08 加入
1828P ARX517: A next generation anti-PSMA antibody drug conjugate (ADC) demonstrates notable stability and pharmacokinetic (PK) profile in the ARX517 phase I clinical trial (APEX-01)
20天前
已关闭
Clinical Pharmacology Characterization and Dose Selection of Xaluritamig, a Next Generation XmAb® 2+1 T‐Cell Engager, in Prostate Cancer Patients
2个月前
已完结
STEAP1-targeted strategies in advanced prostate cancer: a review on therapeutic and diagnostic implications
2个月前
已完结
Therapeutic targeting of eukaryotic initiation factor (eIF) 4E
10个月前
已完结
Unveiling Promising PARP12 Inhibitors through Virtual Screening for Cancer Therapy
11个月前
已完结
皖公网安备34019202002308
